Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-10-017079
Filing Date
2010-03-31
Accepted
2010-03-31 11:30:08
Documents
6
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 v179147_10ka.htm 10-K/A 73699
2 v179147_ex31-1.htm EX-31.1 11319
3 v179147_ex31-2.htm EX-31.2 11171
4 v179147_ex32-1.htm EX-32.1 6806
5 v179147_ex32-2.htm EX-32.2 6820
6 v179147_ex99-1.htm EX-99.1 165627
  Complete submission text file 0001144204-10-017079.txt   276958
Mailing Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618
Business Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618 949-336-7111
NURX PHARMACEUTICALS, INC. (Filer) CIK: 0001174228 (see all company filings)

EIN.: 870681500 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52037 | Film No.: 10717211
SIC: 2833 Medicinal Chemicals & Botanical Products